On August 25, 2026, Baxter International issued a voluntary nationwide recall of two lots of its 0.9% Sodium Chloride Injection after discovering possible fiberglass particulate contamination, and Illinois is one of the states where the affected product was distributed. If the contaminated IV fluid was administered to you or a loved one, you may be entitled to compensation from the manufacturer under Illinois product liability law.
If you or a family member received IV saline at an Illinois hospital or clinic between late July and early August 2026 and suffered complications, call Phillips Law Offices at (312) 346-4262 for a free consultation. We handle defective medical product cases throughout Illinois.
What Was Recalled
| Detail | Information |
|---|---|
| Product | 0.9% Sodium Chloride Injection, USP |
| Container | 500 mL Viaflex plastic containers |
| Lot numbers | Y495523 and Y495523A |
| Manufacturer | Baxter International Inc. |
| Recall announced | August 25, 2026 |
| Distribution window | July 31, 2026 – August 3, 2026 |
| Contaminant identified | Fiberglass / particulate matter |
| States affected | Florida, Illinois, Indiana, Louisiana, Maryland, Missouri, New Jersey, Nevada, New York, North Carolina, Ohio, South Carolina, Texas, Virginia |
Why Fiberglass in an IV Bag Is Dangerous
Sodium chloride injection is administered directly into a patient’s bloodstream, often to critically ill or post-surgical patients who have no way to filter out contaminants before they enter circulation. According to Baxter’s recall notice and the FDA, particulate matter such as fiberglass introduced intravenously can cause:
- Blockage and clotting in small blood vessels
- Pulmonary embolism, a potentially fatal blood clot in the lungs
- Reduced blood flow to vital organs, risking permanent organ damage
- Local tissue irritation, inflammation, or infection at the injection site
- Death, in the most severe cases
As reported by local news outlets, Baxter stated it had not received confirmed reports of adverse events tied to the affected lots as of the recall announcement. That does not mean patients who received these lots are unaffected. Complications from particulate contamination can be subtle, delayed, or misattributed to other causes unless a doctor is specifically looking for them.
Who Is at Risk?
Anyone who received IV sodium chloride from lot Y495523 or Y495523A at a hospital, surgical center, urgent care clinic, or through home infusion therapy in Illinois or the other listed states between late July and early August 2026 may have been exposed. Patients undergoing surgery, receiving IV medications, being treated in an ICU, or receiving hydration therapy are among those most likely to have been given this product.
If you’re unsure whether the saline you or a family member received came from an affected lot, your hospital’s pharmacy or risk management department can often confirm this by checking administration records.
Legal Options for Patients Harmed by Contaminated IV Fluid
Strict Product Liability
Under Illinois law, a manufacturer can be held strictly liable for distributing a defective and unreasonably dangerous product, regardless of how the contamination occurred during manufacturing. A patient does not need to prove Baxter was careless, only that the product was contaminated and that it caused harm.
Negligence
A negligence claim examines whether Baxter’s manufacturing, quality control, or inspection processes fell below the standard of care required for sterile intravenous products, and whether that failure allowed fiberglass particulate to enter the finished product.
Medical Malpractice (in Limited Circumstances)
If a hospital or provider continued administering product from a recalled lot after the recall was announced, or failed to properly monitor a patient who received contaminated fluid, a separate medical malpractice claim may also apply.
Illinois Deadlines to File a Claim
| Claim Type | Time Limit | Illinois Statute |
|---|---|---|
| Product liability | 2 years from discovery of the injury | 735 ILCS 5/13-213 |
| Medical malpractice | 2 years from discovery, 4-year outer limit | 735 ILCS 5/13-212 |
| Wrongful death | 2 years from the date of death | 740 ILCS 180/2 |
What to Do If You Think You Were Affected
- Request your medical records, including the lot number of any IV fluids administered.
- Report new or unexplained symptoms to your doctor immediately, especially signs of a blood clot such as swelling, chest pain, or shortness of breath.
- Keep any physical product or packaging if available.
- Document your treatment and any complications in detail.
- Speak with an attorney before signing anything from Baxter’s insurer or the treating facility.
Frequently Asked Questions
What if I don’t know the lot number of the IV fluid I received?
Hospitals are required to keep records of the lot numbers used for every patient. Your attorney can help you formally request these records from the facility.
Can I file a claim if I haven’t had any symptoms yet?
Particulate injuries can take time to manifest. If you received product from an affected lot, it’s worth having a medical evaluation and preserving your records, even before symptoms appear, so you don’t lose the ability to act if complications surface later.
Is Baxter the only party that could be liable?
Baxter, as the manufacturer, is the primary target of most claims, but depending on the facts, distributors or the treating facility could also bear responsibility.
Talk to an Illinois Defective Medical Product Lawyer
Phillips Law Offices has recovered over $500 million for injured clients since 1945, including cases involving defective medical products and devices. If you or a loved one received recalled Baxter IV saline and suffered complications, call (312) 346-4262 for a free consultation. We work on contingency, you pay nothing unless we win your case.
Related Resources:
